ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Mar 24, 2014 Elite Pharmaceuticals Announces Supplemental Application for Site Transfer of Isradipine

Mar 10, 2014 Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally

Feb 18, 2014 Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201

Feb 10, 2014 lite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014

Nov 14, 2013 Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2014

Aug 12, 2013 Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations

Aug 05, 2013 Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer

Jun 21, 2013 Elite Pharmaceuticals, Inc. Reports Financial Results for the

Jun 19, 2013 Elite Pharmaceuticals, Inc. Announces 2013 Fiscal Year End Conference Call on Monday, June 24, 2013

Jun 10, 2013 Elite Laboratories Files Citizen Petition With The Fda On Brompheniramine Maleate And Pseudoephedrine Hcl Extended Release

8 9 10 11 12 13 14 15 16 17 18

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.